Latest News
Latest Events
Home News Archive

News Archi ve

Title Filter     Display # 
# Article Title Author
1 SPAEN project partner in FP-7 funded EUROSARC project Michaela Geißler
2 SPAEN becomes partner of Rare Cancers Europe Michaela Geißler
3 Meeting of the 8th Pediatric and Wildtype GIST Clinic at NIH Michaela Geißler
4 ASCO 2011 ancillary satellite symposium - Advances in the Care of Patients with GIST: Paths to Progress Michaela Geißler
5 Meeting of the 7th Pediatric and Wildtype GIST Clinic at NIH Michaela Geißler
6 ASCO 2011 Report: Medical highlights in GIST and Sarcomas Michaela Geißler
7 ASCO 2011 News: Ridaforolimus Achieved Primary Endpoint of Improved Progression-Free Survival (PFS) in Metastatic Soft-tissue or Bone Sarcomas Michaela Geißler
8 ASCO 2011 News: Pazopanib improved progression free survival in adults with certain soft tissue sarcomas Michaela Geißler
9 ASCO 2011 News: 36 months adjuvant Imatinib-treatment for high-risk-GISTs improves recurrence-free survival (RFS) and even overall survival (OS) Michaela Geißler
10 Two Chordoma Clinical Trials open in Italy Michaela Geißler
11 The assessment of Bayer HealthCare’s investigational drug regorafenib is to be fast-tracked by US authorities for the treatment of stomach tumours Michaela Geißler
12 A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: Michaela Geißler
13 GIST Nilotinib ERNESTg1 Trial Michaela Geißler
14 9th New Horizons in Treating Cancer: Conference Report Michaela Geißler
15 Jean-Yves Blay: integrating translational and clinical research Michaela Geißler
16 15th Italian Sarcoma Group Annual Meeting 2011 Michaela Geißler
17 EU Register of Clinical Trials is launched online Michaela Geißler
18 Bayer HealthCare has announced the launch of a new Phase III clinical trial Michaela Geißler
19 SPAEN regrets the released information from AB Science: “Masitinib significantly extends overall survival as second-line drug for GIST…” Michaela Geißler
20 Review paper "The Combination of Surgery and Imatinib in GIST: A Reality for Localized Tumors at High Risk, an Open Issue for Metastatic Ones" Michaela Geißler
 
<< Start < Prev 1 2 Next > End >>
Page 1 of 2
Member LogIn



Copyright: SPAEN Sarcoma Patients EuroNet © 2011